SC 13G Filing

Company

Eton Pharmaceuticals, Inc.

Filed

December 9, 2024

Accession Number

0000935836-24-000751

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →